Semaglutide Improves Lipid Subfraction Profiles in Type 2 Diabetes: Insights from a One-Year Follow-Up Study
| dc.contributor.author | Harsányi Adrienn | |
| dc.contributor.author | Dr. Tóth László Imre | |
| dc.contributor.author | Csiha Sára | |
| dc.contributor.author | Molnár Ágnes | |
| dc.contributor.author | Dr. Lőrincz Hajnalka | |
| dc.contributor.author | Nagy Attila Csaba | |
| dc.contributor.author | Prof. Dr. Paragh György | |
| dc.contributor.author | Prof. Dr. Harangi Mariann | |
| dc.contributor.author | Dr. Sztanek Ferenc | |
| dc.contributor.department | Általános Orvostudományi Kar | hu |
| dc.date.accessioned | 2025-12-16T08:39:50Z | |
| dc.date.available | 2025-12-16T08:39:50Z | |
| dc.date.issued | 2025-12 | |
| dc.identifier.uri | https://hdl.handle.net/2437/400204 | |
| dc.title | Semaglutide Improves Lipid Subfraction Profiles in Type 2 Diabetes: Insights from a One-Year Follow-Up Study |
Fájlok
Engedélyek köteg
1 - 1 (Összesen 1)
Nincs kép
- Név:
- license.txt
- Méret:
- 2.57 KB
- Formátum:
- Item-specific license agreed upon to submission
- Leírás: